FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4% is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Ibuprofen; Itraconazole; Terbinafine; Fluconazole.
| Product ID | 72934-4176_87480522-a42d-5023-e053-2995a90afd30 |
| NDC | 72934-4176 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4% |
| Generic Name | Fluconazole 4% / Ibuprofen 2% / Itraconazole 1% / Terbinafine Hcl 4% |
| Dosage Form | Solution |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida, LLC |
| Substance Name | IBUPROFEN; ITRACONAZOLE; TERBINAFINE; FLUCONAZOLE |
| Active Ingredient Strength | 2 g/100g; g/100g; g/100g; g/100g |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Allylamine [CS],Allylamine Antifungal [EPC],Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2019-05-01 |
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 2 g/100g |